TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 SEK)
| Closing information | 2023/03 | 2022/03 | 2021/03 |
| Turnover |
1,606,455
|
1,264,946
|
2,669,392 |
| Earnings before taxes |
31,566
|
59,381
|
1,257,756 |
| Total assets |
735,329
|
864,964
|
2,776,470 |
| Current assets |
621,016
|
773,613
|
2,685,711 |
| Current liabilities |
568,087
|
730,560
|
1,311,116 |
| Equity capital |
143,648
|
112,918
|
1,440,393 |
| - share capital |
15,289
|
14,039
|
13,903 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Solvency |
19.5%
|
13.1%
|
51.9% |
| Turnover per employee |
4,590
|
3,614
|
7,627 |
| Profit as a percentage of turnover |
2.0%
|
4.7%
|
47.1% |
| Return on assets (ROA) | |||
| Current ratio |
109.3%
|
105.9%
|
204.8% |
| Return on equity (ROE) |
22.0%
|
52.6%
|
87.3% |
| Change turnover |
228,808
|
-1,430,512
|
508,814 |
| Change turnover % |
17%
|
-53%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/03 | 2022/03 | 2021/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.